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Abstract: The rapid emergence of AIDS in humans during the period between 1980 and 
2000 has led to extensive efforts to understand more fully similar etiologic agents of 
chronic and progressive acquired immunodeficiency disease in several mammalian species. 
Lentiviruses that have gene sequence homology with human immunodeficiency virus 
(HIV) have been found in different species (including sheep, goats, horses, cattle, cats, and 
several Old World monkey species). Lentiviruses, comprising a genus of the Retroviridae 
family, cause persistent infection that can lead to varying degrees of morbidity and 
mortality depending on the virus and the host species involved. Feline immunodeficiency 
virus (FIV) causes an immune system disease in domestic cats (Felis catus) involving 
depletion of the CD4+ population of T lymphocytes, increased susceptibility to opportunistic 
infections, and sometimes death. Viruses related to domestic cat FIV occur also in a variety 
of nondomestic felids. This is a brief overview of the current state of knowledge of this 
large and ancient group of viruses (FIVs) in South America. 
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1. Introduction 
Feline immunodeficiency virus (FIV) is a Lentivirus, closely related to HIV and SIV, which infects 
members of Felidae family. FIV is an important viral pathogen worldwide in the domestic cat   
(Felis catus), causes a slow progressive degeneration of immune functions that eventually leads to a 
disease. FIV is unique among the nonprimate lentiviruses because in its natural host species it induces 
a disease similar to AIDS in humans infected with human immunodeficiency virus type 1 (HIV-1), 
characterized by a progressive depletion of CD4
+ T lymphocytes [5, 28, 35, 48, 77]. Species-specific 
strains, related to domestic cat FIV, have been isolated from a variety of nondomestic Felidae [11, 43]. 
Like HIV, FIV can be transmitted via mucosal exposure, blood transfer, and vertically either prenatally 
or postnatally [26]. For these reasons, FIV has been studied widely as both an important veterinary 
pathogen and an animal model for HIV/AIDS.  
Figure 1. Distribution of domestic cat immunodeficiency virus (FIV) subtypes in South 
America. The area where all phylogenetic studies were carried out in Brazil is highlighted 
( ). 
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Although FIV was first recognized in 1993 in Brazil [23] and in 1994 in Argentina [65], there are 
few data describing the prevalence, ecology, clinical aspects, or genetic analyses of FIV in South 
America (Figure 1). The prevalence of FIV within the continent is summarized in Table 1. A better 
characterization of FIV strains circulating within South America will be required to augment our 
understanding of the importance of this lentivirus in felids. This paper provides an overview of the 
current state of knowledge of this large and ancient group of viruses (FIVs) in South America, grouped 
according to domestic and nondomestic felids. The data obtained allow a better understanding on FIV 
epidemiology and distribution. Efforts were made to gather and review all of the available information 
for each country. 
Table 1. Epidemiologic studies of Feline immunodeficiency virus (FIV) from South 
America. 
Reference Year 
Country / Geographical 
distribution 
Technique Felid  species 
N
o 
tested 
% 
Positive 
(43) 1992  Brazil/Chile  Western  Blot  Puma concolor  18 0 
(65) 1994  Argentina  Western  Blot  Felis catus  26 34.6 
(52) 1997  Brazil—São  Paulo  ELISA  Felis catus  401 11.7 
(9)  2000  Brazil—Rio Grande do Sul  PCR  Felis catus  40 37.5 
(61) 2002  Brazil—Rio  de  Janeiro  ELISA  Felis catus  126 16.6 
(18) 2003  Brazil—São  Paulo  ELISA 
Leopardus pardalis,  
L. tigrinus, L. wiedii, 
Herpaiturus yaguarondi, 
Oncifelis geoffroyi 
104 0 
(12) 2003  Brazil—Minas  Gerais  PCR  Felis catus  450 2.66 
(64) 2007  Brazil—Minas  Gerais  PCR  Felis catus  145 4.14 
(19) 2006 
Brazil—Roraima; Acre; 
Mato Grosso; Mato Grosso 
do Sul; São Paulo; Rio de 
Janeiro 
ELISA/Western 
Blot 
Puma concolor; Leopardus 
pardalis; Leopardus tigrinus 
21 4.76/9.52 
(21) 2007  Bolivia—Chaco  ELISA 
Leopardus pardalis, 
Oncifelis geoffroyi, 
Herpaiturus yaguarondi 
20 0 
(31) 2008  Brazil—São  Paulo  PCR  Felis catus  454 14.7 
(36) 2008  Ecuador—Galapagos  ELISA  Felis catus  52 0 
(20) 2011  Brazil—São  Paulo 
ELISA/Western 
Blot 
Different species of 
neotropic and exotic felids 
145 6.9  * 
*9 lions and 1 Geoffroy’s cat. 
2. Felis Catus 
FIV infection, in domestic cats, causes a variable immunodeficiency syndrome characterized by 
recurrent gingivitis-stomatitis, cachexia, wasting, neurology, and an increased incidence of tumor 
development [1, 4, 48, 76]. In contrast, the ungulate lentiviruses cause diseases reminiscent of chronic 
inflammatory conditions while infection with the bovine lentivirus seems to be inapparent [71]. The 
rate of progression of the disease can depend on the genotype of the infecting FIV and is also likely 
influenced by undefined genetic determinants of the particular host [16]. FIV infection in domestic cats Viruses 2012, 4  
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is associated with early robust humoral and cellular anti-viral immune responses, followed by a 
progressive immune suppression that results eventually in AIDS. The outcome of infection depends on 
the balance between the viral destruction of the immune system and the ability of the remaining 
immune system to eliminate the virus. Although the decrease in numbers of CD4+ cells is the hallmark 
of FIV infection, the virus has been shown to infect a variety of cell types in their respective hosts 
including CD4
+ and CD8
+ lymphocytes, B lymphocytes, cells of neuronal lineage and 
monocyte/macrophage lineage [15, 17, 29]. Joshi et al. (2005) have characterized feline CD4
+ CD25
+ 
T regulatory cells that support FIV replication. Recently, Reggeti, Ackerley and Bienzle (2008) have 
shown that feline dendritic cells express specific viral receptors and are infected productively by FIV 
[53]. FIV shares a similar pattern of receptor usage to HIV-1; however, CD 134 rather than CD4 is the 
primary binding partner, and subsequent interaction with the secondary receptor CXCR4 permits cells 
entry [58, 72, 73]. Differences in pathogenicity have been demonstrated among genetically distinct 
subtypes of FIV that circulate in domestic cats [14, 16, 49, 63, 68, 73]. On the basis of the analysis of 
envelope glycoprotein (Env), focusing on the third to fifth variable regions (V3-V5), FIV has been 
classified into five subtypes [30, 46, 60] a number that should be expected to increase as further studies 
reveal additional diversity. Recent studies identified distinct groups of FIV isolates from the United 
States and New Zealand [24, 69] (Figure 2). 
Data regarding FIV infection in domestic felids in South America are sparse and have not been well 
evaluated. Expanded surveys of South American isolates will be required to determine the FIV isolates 
in the continent since only few studies have been published. Although there are no doubts about the 
presence of FIV in South America, prevalence data obtained using different techniques cannot be 
compared amongst countries or studies (Table 1). Knowing the prevalence and variability of FIV is 
important for designing and testing vaccines under field conditions [27, 77]. Also, identification of 
circulating subtypes is essential to develop strategies for molecular diagnosis, since the genetic 
diversity of this virus is high [44, 54] which may lead to false negative diagnoses if inappropriate 
primers are used. In South America, only subtype B and E viruses have been found. It is important to 
remember that subtype B viruses are distributed worldwide and that the subtype E viruses have been 
more consistently identified only in Argentina (Figure 1). 
Preliminary studies suggested that FIV infection is widespread in the domestic cat population of 
Brazil [9, 12, 40, 52, 61, 64 ]. A published review indicated that subtype E was the only prevalent in 
Brazil [77]. Nevertheless, all studies indentified B as the only subtype circulating in FIV positive 
animals in Brazil, [12, 32, 40, 62]. Here an analysis was conducted with 473 bp of sequence encoding 
157 amino acids comprising the V3-V4 region of the envelope glycoprotein from different subtypes, 
including those reported previously from South America (Figure 2). In this study we used this region 
of env in order to permit us to include more samples from South America. For this phylogenetic tree, 
the GenBank accession numbers, names, country and subtype for the FIV env sequences included 
were: M25381.1, Petaluma, United States, A; L00608.1, Dixon, United States, A; M59418.1, TM2, 
Japan, B; M36968.1, PPR, United States, A; X69496.1, UK8, England, A; X69494, UK2, Scotland, A; 
X57001, SwissZ2, Switzerland, A; AY621093, FC1, United States (Florida), B; U02392.1, 
CABCpady02C, Canada, C; D84498, LP20, Argentina, E; D84496, LP3, Argentina, E; D84500, LP24, 
Argentina, E; D37813.1, Sendai 1, Japan, A; D37816, Aomori 1, Japan, B; D37814.1, Sendai 2, Japan, 
B; D37812, Yokohama, Japan, B; D37815.1, Fukuoka, Japan, D; D37817.1, Aomori 2, Japan, B; Viruses 2012, 4  
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D37811.1, Shizuoka, Japan, D; AY139094.1, TX125, United States (Texas), F; AY139096.1, TX200, 
United States (Texas), F; AY139097.1, TXMK, United States (Texas), F; EF153977.1, TKP88, New 
Zealand, U; EF153979.1, TKP22, New Zealand, U; EU375619, RJ35, Brazil, B; EU375617, RJ24, 
Brazil, B; EU375616, RJ23, Brazil, B; B; EU375597.1, strain RJ04, Brazil, B; EU375604.1, strain 
RJ11, Brazil, B; EU375606.1, strain RJ13, Brazil, B; EU375608.1, strain RJ15, Brazil, B; 
DQ248885.1, strain 1044MG, Brazil, B; DQ177159.2, strain 945MG, Brazil, B; DQ641681.1, strain 
459MG, Brazil, B; DQ865447.1, strain 301MG, Brazil, B; DQ865449.1, strain 832MG, Brazil, B; 
DQ865454.1, strain 1160MG, Brazil, B. 
Figure 2. Phylogenetic tree of 473 –bp sequences from the V3-V4 region of FIV-Fca env. 
The subtype of the obtained sequences was determined by phylogenetic analysis, using an 
unrooted neighbor joining tree with Kimura2-parameter genetic distances and bootstrap 
analysis with 1000 iterations to evaluate clad consistency.  
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It is important to state that all phylogenetic studies carried out in Brazil were performed in the same 
area, namely the south-east, and that Brazil is a huge country (Figure 1). More widespread surveys of 
Brazilian isolates are required to determine whether a single subtype of FIV predominates in Brazil. In 
Brazilian domestic cats, FIV infected cats have been observed over a prolonged period. During this 
time, few clinical signs were observed, although the virus was replicating and inducing changes in the 
immune system, leading to a progressive decline in immune function and the development later of 
overt clinical signs [51, 78, Hagiwara and Teixeira, unpublished data]. Previously, Brazilian studies 
established relationships between FIV infection and Toxoplasma gondii and Mycoplasma haemofelis 
[37, 39]. Otherwise, no association with disease has been recorded in cases of Brazilian FIV infection. 
It has been suggested that clade B viruses may be more ancient and relatively host adapted and thus 
may be less virulent [2, 50, 63]. 
Preliminary seroepidemiological studies carried out on clinical cases suggested that FIV infection is 
widespread in the domestic cat population of Argentina [65]. The genetic diversity of FIV isolates 
from Argentine domestic cats has been well characterized [47, 75]. FIV isolates were isolated from 
peripheral blood mononuclear cells of four domestic cats. Phylogenetic analysis revealed that one 
isolate clustered with subtype B and the others formed subtype E [47], prototype sequence for this 
group (Figure 2). 
In the north of the continent a single study was performed in 52 domestic cats on Isabela Island, 
Galapagos, Ecuador’s coast. It was demonstrated using serological methods that none of the tested 
animals was infected with FIV [36]. 
3. Nondomestic Felid Species 
Viruses related to domestic cat FIV occur also in nondomestic felids, indeed FIV strains have been 
present in the nondomestic cat population for longer than domestic cats [45]. Carpenter et al. (1996) 
comment that members of at least eighteen of the 37 species in the family Felidae carry an FIV-related 
virus, as has been shown by the presence in their sera of antibodies which react with FIV antigens.  
A further twelve species were reported in another study that employed a three-antigen Western blot 
screening (cat, puma and lion FIV antigens) and a multigene PCR amplification of FIV genes [66]. In 
South America, 12 native species of Felidae’s family are found: Leopardus braccatus; Leopardus 
colocolo;  Leopardus geoffroyi;  Leopardus guingna;  Leopardus jacobita;  Leopardus pajeros; 
Leopardus pardalis;  Leopardus tigrinus;  Leoparuds wiedii;  Puma concolor;  Puma yagouaroundi; 
Panthera onca [74]. Lentiviruses in eight of these species have been detected in South America [6, 10, 
19, 20, 33, 55, 66]. 
Data regarding FIV infections in South American wild felids are sparse and studies have 
concentrated primarily on Brazil. The presence of antibodies against FIV in puma, detected by 
Western blotting, was found in Argentina (5 in 22, 23%), Bolivia (5 in 5, 100%), Brazil (2 in 13, 15%), 
Peru (1 in 5, 20%) and Venezuela (4 in 8, 50%) [10]. Further studies have reported antibodies 
recognizing FIV and the puma lentivirus (PLV in Brazilian free-ranging puma) [6, 19]. Troyer et al. 
(2005) concluded that most of the South American felids maintain a low level of FIV infection 
throughout their population. Within wild populations, the seroprevalence in South American felids 
varies from 5 to 28%. Unfortunately, the authors did not describe the regions of the continent where Viruses 2012, 4  
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the samples originated. FIV pol genes from a Peruvian and a Brazilian zoo puma have been sequenced, 
the former being classified as subtype B and the latter as a distinct group, neither A nor B [10]. 
Additionally, FIV provirus has been reported in Brazilian jaguars (Panthera onca), pumas, jaguarondis 
(Puma yagouaroundi), oncelots (Leopardus pardalis), margays (Leopardus wiedii), pampas cat 
(Leopardus colocolo), geoffroy’s cat (Leopardus geoffroyi) and little spotted cats (Leopardus tigrinus) 
[20, 33, 55]. The finding of these FIV infected species highlights the need for additional monitoring. 
Although the implications of these infections for wild felid conservation are difficult to assess, it is 
generally accepted that monitoring these infections is an important component for the management of 
endangered populations [13]. 
It is important to emphasize that FIV strains infecting 9 species of the Felidae have been at least 
partially sequenced and molecularly characterized [3, 10, 11, 25, 34, 38, 42, 43, 66]. Genetic analysis 
indicates that different felid species are infected by different strains of FIV [8, 11]. Analysis of pol 
gene sequence of FIV from lions (Panthera leo), pumas (Puma concolor) and domestic cats indicated 
that each species has a specific strain of FIV and that the strains are related but distinct [7, 43]. Also, 
strains from African lions (subtype B and E) differ in their abilities to replicate in feline cell lines [59], 
their sensitivity to receptor antagonists [71], and their requirement for ectopic expression of CD134, 
the primary cellular receptor, for productive infection [41]. 
It remains to be demonstrated that FIV-related viruses cause severe disease in species other than the 
domestic cat [6, 38]. The apparent absence of clinical signs in pumas and lions may reflect a longer 
period of coevolution between virus and host in these species, whereas in the domestic cat, the virus 
and host have not yet had time to reach a similar state of nonpathogenic coexistence [6, 7, 57]. 
However, it is by no means certain that FIV does not cause disease in non-domestic cats. Not long ago, 
reports have shown immune depletion associated with FIV infection in lions and pumas [56, 57] and 
another recent study reported evidence of immune suppression in the Pallas’ cat (Otocolobus manul), 
including histopatological changes [8]. In addition, interspecies transmission (although is rare) may 
occur [22, 67]. For example, a leopard cat (Felis bengalensis) was found to be infected with a domestic 
cat virus [42] and FIV infecting one puma was more characteristic of domestic cat FIV rather than 
puma FIV [10]. 
4. Conclusions 
The prevalence of FIV infection is South America has not been well evaluated and regional 
variations remain largely unexplored in domestic and wild cats. Considering that FIV has been 
detected in domestic cats in South America and that wild and domestic cats have overlapping 
territories in the communities and buffer zone, there is the potential for domestic felids to transmit this 
virus to naive wild felids in zoologic as well as free-range settings. The isolation and molecular 
characterization of these pathogens, both in domestic and a variety of wild felines, would be helpful 
and may provide important baseline data to develop effective programs aimed at infectious disease 
prevention. We believe that the feline population should be continually monitored for FIV infection 
and that clinical correlates to FIV infection should be further investigated. As recently proposed [70], 
researchers could consider early surveillance programs across defined populations and detailed, cohort 
studies of naturally infected animals to provide further insights. Such studies would provide an Viruses 2012, 4  
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opportunity to track retrospectively the pattern and consequences of an ongoing epizootic. There are 
technical reasons that hinder such studies, there is an urgent need for increased capacity in South 
American laboratories in order to conduct FIV screening and the apparent absence of FIV infection in 
some countries of the continent may merely reflect an absence of investigations. In addition, it is not 
easy to study FIV in wild cats as it is difficult to obtain samples from wild populations and only when 
these difficulties are overcome will it be possible to analyze and characterize FIV strains from the 
continent. 
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